Amalgamated Financial’s PDL BioPharma, Inc. PDLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$22K Buy
+8,806
New +$22K ﹤0.01% 2727

Amalgamated Financial's PDLI Position: Q1 2022 in Review

Amalgamated Financial opened a new position in PDL BioPharma, Inc. (PDLI) in Q1 2022: 8,806 shares worth $22K. The stake represents ﹤0.01% of the portfolio and ranks #2727 among its holdings.

5 funds tracked by Wall St. Rank hold PDLI as of Q1 2022.

  • Amalgamated Financial held 8,806 shares of PDL BioPharma, Inc. worth $22K as of Q1 2022.
  • PDL BioPharma, Inc. was a new Amalgamated Financial position in Q1 2022.
  • PDL BioPharma, Inc. made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #2727 holding.
  • 5 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.